<code id='B25C658ECE'></code><style id='B25C658ECE'></style>
    • <acronym id='B25C658ECE'></acronym>
      <center id='B25C658ECE'><center id='B25C658ECE'><tfoot id='B25C658ECE'></tfoot></center><abbr id='B25C658ECE'><dir id='B25C658ECE'><tfoot id='B25C658ECE'></tfoot><noframes id='B25C658ECE'>

    • <optgroup id='B25C658ECE'><strike id='B25C658ECE'><sup id='B25C658ECE'></sup></strike><code id='B25C658ECE'></code></optgroup>
        1. <b id='B25C658ECE'><label id='B25C658ECE'><select id='B25C658ECE'><dt id='B25C658ECE'><span id='B25C658ECE'></span></dt></select></label></b><u id='B25C658ECE'></u>
          <i id='B25C658ECE'><strike id='B25C658ECE'><tt id='B25C658ECE'><pre id='B25C658ECE'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:6152
          STAT Q&A
          Paul Matteis (right), in 2017 with then-colleagues Seamus Fernandez (far left) Geoffrey Porges. Alex Hogan/STAT

          NEW YORK — Is biotech having a renaissance in neuroscience? Can we solve the placebo effect? And what’s going to happen next year?

          Paul Matteis, co-head of biotech research at Stifel, sat down with STAT at the firm’s annual health care conference here to field those questions and opine on how management teams can walk the delicate balance between hype and sandbagging. This transcript has been edited for length and clarity.

          advertisement

          One thing I’ve been hearing lately is that biotech has entered a sort of renaissance in neuroscience. Do you agree with that?

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          Why 40% Americans with Parkinson’s don’t see a neurologist
          Why 40% Americans with Parkinson’s don’t see a neurologist

          RichardHuckabee,seenwithhiswife,Angela,saysittooknineyearstobediagnosedwithParkinson’s.CourtesyRicha

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

          2:07E.JeanCarrollwalksoutofManhattanfederalcourt,May9,2023,inNewYork.JohnMinchillo/AP,FILETheJustice